LIFECORE BIOMEDICAL, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
LIFECORE BIOMEDICAL, INC. (LFCR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.95 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 12.95M shares.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 12.96M shares.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 11.94M shares.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-05-25 was 12.42M shares.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 12.33M shares.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 1.58M shares, a 5.45% increase from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2018 was 1.50M shares, a 4.70% increase from fiscal 2017.
- LIFECORE BIOMEDICAL, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 1.43M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.95M shares 10-Q · filed 2026-08-05 | 12.95M shares 10-Q · filed 2026-08-05 | |||||
| 2026-03-31 | 12.96M shares 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | 12.50M shares 10-KT · filed 2026-03-16 | ||||||
| 2025-09-30 | 11.94M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-05-25 | 12.42M shares 10-Q · filed 2026-08-05 | 12.42M shares 10-Q · filed 2026-08-05 | 12.33M shares 10-KT · filed 2026-03-16 | ||||
| 2025-02-23 | 12.09M shares 10-Q · filed 2026-05-06 | 12.00M shares 10-Q · filed 2025-04-03 | |||||
| 2024-11-24 | 7.02M shares 10-Q · filed 2025-01-02 | 6.93M shares 10-Q · filed 2025-01-02 | |||||
| 2024-08-25 | 11.19M shares 10-Q · filed 2025-11-06 | 6.10M shares 10-Q · filed 2024-10-04 | |||||
| 2023-08-27 | 5.96M shares 10-Q · filed 2024-10-04 | ||||||
| 2019-11-24 | 2.30M shares 10-Q · filed 2020-01-02 | 2.50M shares 10-Q · filed 2020-01-02 | |||||
| 2019-08-25 | 2.60M shares 10-Q · filed 2019-10-03 | ||||||
| 2019-05-26 | 1.58M shares 10-K · filed 2019-08-01 | ||||||
| 2019-02-24 | 1.90M shares 10-Q · filed 2019-04-04 | 1.60M shares 10-Q · filed 2019-04-04 | |||||
| 2018-11-25 | 1.50M shares 10-Q · filed 2020-01-02 | 1.40M shares 10-Q · filed 2020-01-02 | |||||
| 2018-08-26 | 1.40M shares 10-Q · filed 2019-10-03 | ||||||
| 2018-05-27 | 1.50M shares 10-K · filed 2019-08-01 | ||||||
| 2018-02-25 | 1.70M shares 10-Q · filed 2019-04-04 | 1.50M shares 10-Q · filed 2019-04-04 | |||||
| 2017-11-26 | 1.30M shares 10-Q · filed 2019-01-07 | 1.50M shares 10-Q · filed 2018-01-05 | 1.40M shares 10-Q · filed 2019-01-07 | ||||
| 2017-08-27 | 1.30M shares 10-Q · filed 2018-10-05 | ||||||
| 2017-05-28 | 1.43M shares 10-K · filed 2019-08-01 | ||||||
| 2017-02-26 | 1.20M shares 10-Q · filed 2017-04-07 | 1.40M shares 10-Q · filed 2017-04-07 | |||||
| 2016-11-27 | 1.27M shares 10-Q · filed 2017-01-05 | 1.42M shares 10-Q · filed 2017-01-05 | |||||
| 2016-08-28 | 1.39M shares 10-Q · filed 2016-09-29 | ||||||
| 2016-02-28 | 1.60M shares 10-Q · filed 2017-04-07 | 1.50M shares 10-Q · filed 2017-04-07 | |||||
| 2015-11-29 | 1.14M shares 10-Q · filed 2017-01-05 | 1.10M shares 10-Q · filed 2016-01-07 | 1.12M shares 10-Q · filed 2017-01-05 | 1.10M shares 10-Q · filed 2016-01-07 | |||
| 2015-08-30 | 1.08M shares 10-Q · filed 2016-09-29 | ||||||
| 2015-05-31 | 371.12K shares 10-K/A · filed 2018-03-15 | ||||||
| 2015-03-01 | 390.66K shares 10-Q · filed 2016-03-30 | 349.08K shares 10-Q · filed 2016-03-30 | |||||
| 2014-11-30 | 321.50K shares 10-Q · filed 2015-01-09 | 329.06K shares 10-Q · filed 2016-01-07 | |||||
| 2014-08-31 | 336.07K shares 10-Q · filed 2015-10-01 | ||||||
| 2014-05-25 | 333.99K shares 10-K · filed 2016-08-01 | ||||||
| 2014-02-23 | 342.50K shares 10-Q · filed 2014-03-28 | 332.04K shares 10-Q · filed 2014-03-28 | |||||
| 2013-11-24 | 342.50K shares 10-Q · filed 2015-01-09 | 273.88K shares 10-Q · filed 2015-01-09 | |||||
| 2013-08-25 | 256.26K shares 10-Q · filed 2014-10-08 | ||||||
| 2013-05-26 | 88.02K shares 10-K · filed 2015-07-31 | ||||||
| 2013-02-24 | 95.53K shares 10-Q · filed 2014-03-28 | 88.13K shares 10-Q · filed 2014-03-28 | |||||
| 2012-11-25 | 85.86K shares 10-Q · filed 2014-01-03 | 84.43K shares 10-Q · filed 2014-01-03 | |||||
| 2012-08-26 | 277.49K shares 10-Q · filed 2013-09-26 | ||||||
| 2012-05-27 | 1.86M shares 10-K · filed 2014-08-01 | ||||||
| 2012-02-26 | 1.90M shares 10-Q · filed 2013-04-04 | 2.00M shares 10-Q · filed 2013-04-04 | |||||
| 2011-11-27 | 2.10M shares 10-Q · filed 2013-01-04 | 2.10M shares 10-Q · filed 2013-01-04 | |||||
| 2011-08-26 | 1.80M shares 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |